BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...
Credit: Shutterstock. Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler. The Food and Drug Administration (FDA) has cleared Cerament G for use as a bone void filler in skeletally ...
This is a prospective, single cohort study of children admitted to a tertiary referral pediatric hospital for suspected or confirmed bacterial infection, who commenced an antibiotic regimen that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results